Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases

1 James JA Harley JB Scofield RH . Epstein–Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol 2006; 18: 462 – 467 .

2 Arbuckle MR McClain MT Rubertone MV . Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526 – 1533 .

3 McClain MT Heinlen LD Dennis GJ Roebuck J Harley JB James JA . Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 2005; 11: 85 – 89 .

4 McNeil HP Simpson RJ Chesterman CN Krilis SA . Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990; 87: 4120 – 4124 .

5 Giles IP Isenberg DA Latchman DS Rahman A . How do antiphospholipid antibodies bind beta2-glycoprotein I? Arthritis Rheum 2003; 48: 2111 – 2121 .

6 Bouma B de Groot PG van den Elsen JM . Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J 1999; 18: 5166 – 5174 .

7 Iverson GM Victoria EJ Marquis DM . Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. Proc Natl Acad Sci U S A 1998; 95: 15,542 – 15,546 .

8 Iverson GM Reddel S Victoria EJ . Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. J Immunol 2002; 169: 7097 – 7103 .

9 Ioannou Y Giles I Lambrianides A . A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli. BMC Biotechnol 2006; 6: 8 .

10 Ioannou Y Pericleous C Giles I Latchman DS Isenberg DA Rahman A . Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum 2007; 56: 280 – 290 .

11 Ioannou Y Harper T Romay-Penabad Z . Domain I of beta-2-glycoprotein I ameliorates thrombosis induced by antiphospholipid antibodies in mice. Arthritis Rheum 2006; 54(Suppl. 9): S559 .

12 Winkler TH Fehr H Kalden JR . Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur J Immunol 1992; 22: 1719 – 1728 .

13 Wellmann U Letz M Herrmann M Angermuller S Kalden JR Winkler TH . The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci U S A 2005; 102: 9258 – 9263 .

14 Baumann I Kolowos W Voll RE . Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002; 46: 191 – 201 .

15 Neuberger MS Milstein C . Somatic hypermutation. Curr Opin Immunol 1995; 7: 248 – 254 .

16 Radic MZ Weigert M . Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 1994; 12: 487 – 520 .

17 Riemekasten G Marell J Trebeljahr G . A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J Clin Invest 1998; 102: 754 – 763 .

18 Langer S Langnickel D Enghard P . The systemic and SmD183-119-autoantigen-specific cytokine memory of Th cells in SLE patients. Rheumatology (Oxford) 2007; 46: 238 – 245 .

19 Dragun D Muller DN Brasen JH . Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558 – 569 .

20 Wallukat G Homuth V Fischer T . Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999; 103: 945 – 952 .